As of 2025-07-15, the Intrinsic Value of Samjin Pharmaceutical Co Ltd (005500.KS) is 31,095.40 KRW. This 005500.KS valuation is based on the model Discounted Cash Flows (Growth Exit 5Y). With the current market price of 20,300.00 KRW, the upside of Samjin Pharmaceutical Co Ltd is 53.20%.
The range of the Intrinsic Value is 24,258.86 - 41,974.38 KRW
Based on its market price of 20,300.00 KRW and our intrinsic valuation, Samjin Pharmaceutical Co Ltd (005500.KS) is undervalued by 53.20%.
| Range | Selected | Upside | |
| a | |||
| DCF (Growth 5y) | 24,258.86 - 41,974.38 | 31,095.40 | 53.2% |
| DCF (Growth 10y) | 36,833.38 - 61,558.53 | 46,398.20 | 128.6% |
| DCF (EBITDA 5y) | 32,885.75 - 53,965.71 | 40,929.44 | 101.6% |
| DCF (EBITDA 10y) | 41,373.39 - 67,081.78 | 51,269.59 | 152.6% |
| Fair Value | 71,684.00 - 71,684.00 | 71,684.00 | 253.12% |
| P/E | 22,784.68 - 87,397.12 | 45,451.14 | 123.9% |
| EV/EBITDA | 19,201.69 - 36,290.31 | 24,550.45 | 20.9% |
| EPV | (10,462.71) - (11,103.40) | (10,783.02) | -153.1% |
| DDM - Stable | 21,292.68 - 42,988.58 | 32,140.65 | 58.3% |
| DDM - Multi | 24,643.55 - 40,101.15 | 30,645.04 | 51.0% |
| Market Cap (mil) | 282,170.00 |
| Beta | 0.59 |
| Outstanding shares (mil) | 13.90 |
| Enterprise Value (mil) | 400,176.00 |
| Market risk premium | 5.82% |
| Cost of Equity | 8.21% |
| Cost of Debt | 4.51% |
| WACC | 6.89% |